Joel Greenblatt's position in Organon is currently worth $9.37 Million. That's 0.17% of their equity portfolio (119th largest holding). The first Organon trade was made in Q2 2021. Since then Joel Greenblatt bought shares six more times and sold shares on four occasions. The investor's estimated purchase price is $11.1 Million, resulting in a loss of 15%.